APLS
Apellis Pharmaceuticals, Inc.
Commercial-stage biopharmaceutical company developing novel therapeutic compounds for rare diseases
CUSIP: 03753U106HealthcareUS1 holder
Total Value
$3.61M
Total Shares
143.8K
Net Share Change
+143.8K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Bridgewater Associates LP
$3.61M143.8K sharesNEW